Trusted Press Release Distribution   Join | Login    

Briefing Search


Author Details
QYResearch Publisher

Bookmark and Share
Global Rho Associated Protein Kinase 2 Market Expected to Witness a Sustainable Growth over 2025
The global Rho Associated Protein Kinase 2 market was million US$ in 2017 and is expected to million US$ by the end of 2025, growing at a CAGR of % between 2018 and 2025., 7/13/2018 - This report studies the Rho Associated Protein Kinase 2 market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Rho associated coiled-coil containing protein kinase 2 is a protein that in humans is encoded by the ROCK2 gene. The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1, is a target for the small GTPase Rho.

In the last several years, global market of Rho Associated Protein Kinase 2 developed rapidly, with an average growth rate of 68%. In 2017, Global Market Size of Rho Associated Protein Kinase 2 is nearly 850 K USD.

For developing product, there are 1 product in Phase 3, 2 products in Phase 2, 0 products in Phase 1 and 6 products in Preclinical. The total investment for Rho Associated Protein Kinase 2 developing is around 88 M USD in 2017.

The Application of Rho Associated Protein Kinase 2 includes Glaucoma, Spinal Cord, Chronic Obstructive Pulmonary Disease, Immune Therapy and Others, and the proportion of R&D Investmen for Glaucoma in 2017 is about 67%, and the proportion is in decrease trend from 2012 to 2016.

The global Rho Associated Protein Kinase 2 market was million US$ in 2017 and is expected to million US$ by the end of 2025, growing at a CAGR of % between 2018 and 2025.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The leading players include following list:

Aerie Pharmaceuticals

Kadmon Corporation

BioAxone BioSciences Inc

Redx Pharma

Angion Biomedica


HitGen LTD

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States







South Korea








Rest of Asia-Pacific








Rest of Europe

Central & South America


Rest of Central & South America

Middle East & Africa

GCC Countries



South Africa

Rest of Middle East & Africa

Request Sample Report and TOC@

About Us: QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Contact US

QY Research, INC.

17890 Castleton, Suite 218,

City of industry, CA – 91748

USA: +1 626 295 2442



For other region, contact number given below

+86 108 294 5717 Beijing

+81 903 800 9273 Japan

+91 114 046 9822 India

FAQs | Contact Us | Terms & Conditions | Privacy Policy
© 2013 Proserve Technology, Inc.